SBIR Phase I: Novel Biomimetic Production of Broad-Spectrum Fungicide BioSurF-I
SBIR 第一阶段:广谱杀菌剂 BioSurF-I 的新型仿生生产
基本信息
- 批准号:1721879
- 负责人:
- 金额:$ 22.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:Standard Grant
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-07-01 至 2018-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project will be the development of a biofungicide for application on organic farms as well as conventional farms and home and lawn care as an alternative to chemical fungicides. More than 70% of all major crop diseases are caused by fungi. Despite intensive disease control practices, these pathogens are still causing crop losses averaging 13% with economic losses up to $100 billion annually. The proposed research will address the need for sustainable food production by development of methods/technologies to reduce or eliminate the usage of chemical pesticides. It will reduce the impact of plant pathogens, insect pests, and abiotic stresses on crop plants by inducing systemic resistance in crops. Unlike chemical fungicides, it will be eco-friendly and will prevent development of anti-fungal resistance in plant pathogens. Furthermore, reduction in chemical fungicide usage (produced using fossil fuels) will reduce US dependence on fossil fuels and promote environmental sustainability. This SBIR Phase I project proposes to develop a novel, broad spectrum, biofungicide for crop protection as an alternative to chemical fungicides. The novel broad spectrum fungicide is based on a fermentative strategy utilizing non-pathogenic microorganisms and low-cost carbon substrates. Antifungal activity testing in in vitro and in vivo assays demonstrated broad spectrum fungicidal activity against multiple fungal pathogens that cause diseases in cereals, fruit, and vegetable crops. The use of chemical fungicides produced from fossil fuels has been shown to have adverse environmental effects on non-target organisms, and mammals. In addition, combinations of chemical fungicides are required to attain crop protection, yet fungal pathogens quickly become resistant to chemical fungicides. The proposed broad spectrum biofungicide has no mammalian toxicity, and has been shown to be safe for non-target anthropods like honey bees. It also has been shown to not inhibit the growth of beneficial fungi. As part of the Phase I research plan, the aims are to scale up production and test the biofungicide under development in small plot trials.
这项小型企业创新研究(SBIR)项目的更广泛影响/商业潜力将是开发一种生物杀菌剂,用于有机农场和传统农场以及家庭和草坪护理,作为化学杀菌剂的替代品。70%以上的主要作物病害是由真菌引起的。尽管采取了强化的疾病控制措施,这些病原体仍造成平均13%的作物损失,每年经济损失高达1000亿美元。拟议的研究将通过开发减少或消除化学农药使用的方法/技术来解决可持续粮食生产的需要。它将通过诱导作物的系统抗性来减少植物病原体、害虫和非生物胁迫对作物的影响。与化学杀菌剂不同,它将是生态友好的,并将防止植物病原体产生抗真菌抗性。此外,减少化学杀菌剂的使用(使用化石燃料生产)将减少美国对化石燃料的依赖,促进环境的可持续性。该SBIR一期项目建议开发一种新型、广谱的作物保护生物杀菌剂,作为化学杀菌剂的替代品。新型广谱杀菌剂是基于利用非致病微生物和低成本碳底物的发酵策略。体外和体内抗真菌活性测试表明,对谷物、水果和蔬菜作物中引起疾病的多种真菌病原体具有广谱的杀真菌活性。使用由化石燃料生产的化学杀菌剂已被证明对非目标生物和哺乳动物有不利的环境影响。此外,为了获得作物保护,需要化学杀菌剂的组合,但真菌病原体很快就会对化学杀菌剂产生抗药性。提出的广谱生物杀菌剂对哺乳动物没有毒性,并且已被证明对蜜蜂等非目标人类类动物是安全的。它也被证明不会抑制有益真菌的生长。作为第一阶段研究计划的一部分,目标是扩大生产规模,并在小块试验中测试正在开发的生物杀菌剂。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nadia Adam其他文献
Twisted Gastrulation Modulates Bone Morphogenetic Protein-induced Collagen II and X Expression in Chondrocytes <em>in Vitro</em> and <em>in Vivo</em>
- DOI:
10.1016/s0021-9258(19)84094-2 - 发表时间:
2006-10-20 - 期刊:
- 影响因子:
- 作者:
Martina Schmidl;Nadia Adam;Cordula Surmann-Schmitt;Takako Hattori;Michael Stock;Uwe Dietz;Benoit de Crombrugghe;Ernst Po¨schl;Klaus von der Mark - 通讯作者:
Klaus von der Mark
Nadia Adam的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Nadia Adam', 18)}}的其他基金
SBIR Phase I: Broad Spectrum biorational bio- and synthetic insecticides and mosquito repellents
SBIR 第一阶段:广谱生物合理的生物和合成杀虫剂和驱蚊剂
- 批准号:
1938569 - 财政年份:2020
- 资助金额:
$ 22.49万 - 项目类别:
Standard Grant
Organic Acid Promoted Dissolution of Phosphate as Affected by its Solid State Speciation in Single and Mixed Fe, Al, Ca Mineral Systems: Implications for Phosphorus Bioavailability
有机酸促进磷酸盐溶解,受单一和混合 Fe、Al、Ca 矿物系统中固态形态的影响:对磷生物利用率的影响
- 批准号:
0819962 - 财政年份:2008
- 资助金额:
$ 22.49万 - 项目类别:
Standard Grant
相似国自然基金
Baryogenesis, Dark Matter and Nanohertz Gravitational Waves from a Dark
Supercooled Phase Transition
- 批准号:24ZR1429700
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
ATLAS实验探测器Phase 2升级
- 批准号:11961141014
- 批准年份:2019
- 资助金额:3350 万元
- 项目类别:国际(地区)合作与交流项目
地幔含水相Phase E的温度压力稳定区域与晶体结构研究
- 批准号:41802035
- 批准年份:2018
- 资助金额:12.0 万元
- 项目类别:青年科学基金项目
基于数字增强干涉的Phase-OTDR高灵敏度定量测量技术研究
- 批准号:61675216
- 批准年份:2016
- 资助金额:60.0 万元
- 项目类别:面上项目
基于Phase-type分布的多状态系统可靠性模型研究
- 批准号:71501183
- 批准年份:2015
- 资助金额:17.4 万元
- 项目类别:青年科学基金项目
纳米(I-Phase+α-Mg)准共晶的临界半固态形成条件及生长机制
- 批准号:51201142
- 批准年份:2012
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
连续Phase-Type分布数据拟合方法及其应用研究
- 批准号:11101428
- 批准年份:2011
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
D-Phase准晶体的电子行为各向异性的研究
- 批准号:19374069
- 批准年份:1993
- 资助金额:6.4 万元
- 项目类别:面上项目
相似海外基金
SBIR Phase II: Development of a Novel Measurement Technology to Enable Longitudinal Multiomic Investigations of the Gut Microbiome
SBIR 第二阶段:开发新型测量技术以实现肠道微生物组的纵向多组学研究
- 批准号:
2314685 - 财政年份:2024
- 资助金额:
$ 22.49万 - 项目类别:
Cooperative Agreement
SBIR Phase I: Novel Self-Closing, Transcatheter, Edge-to-Edge Repair Device to Percutaneously Treat Tricuspid Valve Regurgitation Using Jugular or Femoral Vein Access
SBIR 第一阶段:新型自闭合、经导管、边对边修复装置,利用颈静脉或股静脉通路经皮治疗三尖瓣反流
- 批准号:
2322197 - 财政年份:2024
- 资助金额:
$ 22.49万 - 项目类别:
Standard Grant
SBIR Phase I: Novel Camera-Projector Device Leveraging Markerless Skin Registration and Projected Augmented Reality Software to Enable Navigation for Minimally Invasive Procedures
SBIR 第一阶段:新型相机投影仪设备利用无标记皮肤配准和投影增强现实软件实现微创手术导航
- 批准号:
2321906 - 财政年份:2024
- 资助金额:
$ 22.49万 - 项目类别:
Standard Grant
SBIR Phase I: Universal Crystal Growth Capsule and Novel Wafer Dicing Tool for In-Space Manufacturing
SBIR 第一阶段:用于太空制造的通用晶体生长舱和新型晶圆切割工具
- 批准号:
2419346 - 财政年份:2024
- 资助金额:
$ 22.49万 - 项目类别:
Standard Grant
SBIR Phase I: Optimizing Composition of Novel Molten Alkali Metal Borates for Carbon Dioxide Capture
SBIR 第一阶段:优化用于二氧化碳捕获的新型熔融碱金属硼酸盐的成分
- 批准号:
2332658 - 财政年份:2024
- 资助金额:
$ 22.49万 - 项目类别:
Standard Grant
SBIR Phase II: Novel progesterone biosensor for monitoring fertility health
SBIR II 期:用于监测生育健康的新型黄体酮生物传感器
- 批准号:
2341568 - 财政年份:2024
- 资助金额:
$ 22.49万 - 项目类别:
Cooperative Agreement
SBIR Phase II: Novel size-changing, gadolinium-free contrast agent for magnetic resonance angiography
SBIR II 期:用于磁共振血管造影的新型尺寸变化、无钆造影剂
- 批准号:
2322379 - 财政年份:2023
- 资助金额:
$ 22.49万 - 项目类别:
Cooperative Agreement
SBIR Phase I: Development of novel artificial intelligence (AI)-enabled, non-invasive, heart attack diagnostics
SBIR 第一阶段:开发新型人工智能 (AI) 支持的非侵入性心脏病诊断
- 批准号:
2208248 - 财政年份:2023
- 资助金额:
$ 22.49万 - 项目类别:
Standard Grant
SBIR Phase I: Consolidated platform to engineer and produce novel biopolymers for improved biologics
SBIR 第一阶段:设计和生产新型生物聚合物以改进生物制剂的综合平台
- 批准号:
2233560 - 财政年份:2023
- 资助金额:
$ 22.49万 - 项目类别:
Standard Grant
SBIR Phase I: Engineered Induced Thymic Epithelial Cells for Novel T Cell Immunotherapies
SBIR 第一期:用于新型 T 细胞免疫疗法的工程诱导胸腺上皮细胞
- 批准号:
2234041 - 财政年份:2023
- 资助金额:
$ 22.49万 - 项目类别:
Standard Grant